NEW YORK Celebrex, the nation's leading arthritis painkiller, raises the risk of heart attack when taken at very high doses, the drug's maker said Friday in the latest blow to a class of powerful and ...
NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...
The National Institutes of Health, which suspended the cancer study, ordered a full review of all studies involving the cox-2 drugs. The Celebrex warning comes little more than two months after its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results